Liver Transplantation 2023: Status Report, Current and Future Challenges
- PMID: 37084928
- DOI: 10.1016/j.cgh.2023.04.005
Liver Transplantation 2023: Status Report, Current and Future Challenges
Abstract
Liver transplantation offers live-saving therapy for patients with complications of cirrhosis and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and innovations aimed at increasing the number of usable deceased donors as well as alternative donor sources are a major focus. The etiologies of cirrhosis are shifting over time, with more need for transplantation among patients with alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease and less for viral hepatitis, although hepatitis B remains an important indication for transplant in countries with high endemicity. The rise in transplantation for alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease has brought attention to how patients are selected for transplantation and the strategies needed to prevent recurrent disease. In this review, we present a status report on the most pressing topics in liver transplantation and future challenges.
Keywords: Alcohol-associated Liver Disease; Alcoholic Hepatitis; Allocation; Equity; Extended Criteria Donor; Fatty Liver; Hepatitis B; Hepatitis C; Liver Cancer; MELD; Machine Perfusion; Xenotransplantation.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
